Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07428031

French Registry: Late Gadolinium Enhancement in Hypertrophic Cardiomyopathy

Retrospective French Registry of Cardiovascular Magnetic Resonance Late Gadolinium Enhancement in Patients With Hypertrophic Cardiomyopathy

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
5,000 (estimated)
Sponsor
Assistance Publique - Hôpitaux de Paris · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study aims to create a registry of patients with hypertrophic cardiomyopathy, a condition characterized by excessive thickening of the heart muscle. This disease can sometimes lead to serious complications. Currently, the prognosis of these patients is mainly determined by clinical and echocardiographic parameters. Detection of myocardial fibrosis using cardiac MRI enables better risk stratification for these patients.

Conditions

Timeline

Start date
2026-03-01
Primary completion
2031-03-01
Completion
2036-03-01
First posted
2026-02-23
Last updated
2026-02-23

Source: ClinicalTrials.gov record NCT07428031. Inclusion in this directory is not an endorsement.

French Registry: Late Gadolinium Enhancement in Hypertrophic Cardiomyopathy (NCT07428031) · Clinical Trials Directory